tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Income Statement

Compare
2,124 Followers

Aquestive Therapeutics Income Statement

Last quarter (Q3 2024), Aquestive Therapeutics's total revenue was $13.54M, an increase of 4.15% from the same quarter last year. In Q3, Aquestive Therapeutics's net income was $-11.51M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 50.58M$ 47.68M$ 50.83M$ 45.85M$ 52.61M
Gross Profit
$ 29.75M$ 28.29M$ 35.84M$ 32.88M$ 32.25M
Operating Expenses
$ 44.85M$ 70.36M$ 70.52M$ 75.78M$ 84.92M
Depreciation and Amortization
$ 1.34M$ 2.39M$ 2.96M$ 3.61M$ 3.05M
EBITDA
$ 1.18M$ -39.58M$ -45.11M$ -39.15M$ -53.88M
Operating Income
$ -15.10M$ -42.07M$ -34.68M$ -42.89M$ -52.67M
Other Income/Expenses
$ 7.48M$ -12.34M$ -35.86M$ -12.89M$ -13.58M
Pretax Income
$ -7.63M$ -54.41M$ -70.54M$ -55.78M$ -66.25M
Net Income
$ -7.87M$ -60.20M$ -90.04M$ -65.36M$ -72.66M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.13$ -1.24$ -2.36$ -1.94$ -2.87
Diluted EPS
$ -0.13$ -1.24$ -2.36$ -1.94$ -2.87
Weighted Average Shares Outstanding
61.26M 48.73M 38.08M 33.65M 25.36M
Weighted Average Shares Outstanding (Diluted)
61.26M 48.73M 38.08M 33.65M 25.36M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis